Skip to content
AnimalThymus peptide for immune modulation

Thymulin

Thymus peptide for immune balance & T-cell maturation.

Overview

Binds to specific receptors on thymocytes and mature T-cells, requiring zinc for biological activity.

Proposed mechanism

Nonapeptide produced by thymic epithelial cells that induces T-cell differentiation and modulates cytokine production.

What the evidence supports

Most data comes from preclinical animal studies. Human clinical trial evidence is limited or absent.

Graded Animal

Evidence drawn from in vivo animal models or in vitro systems. Mechanistically informative; translation to humans is unproven.

Key citations

Representative primary sources, including results that did not favour the compound.

  1. [1]

    Thymulin and immunity

    · DOI:10.1016/S0165-2478(99)00157-3 · 1999

  2. [2]

    Thymic peptides review

    · DOI:10.1016/j.cyto.2017.07.020 · 2017

  3. [3]

    Thymulin and immunity (1999)

    · · 0

  4. [4]

    Thymic peptides review (2017)

    · · 0

Citation records in this build are illustrative placeholders for the design.

Reference information for research purposes. Not medical advice, and not a recommendation to use any compound. Many entries describe substances that are not approved for human use.

Related profiles